Modified pork could revolutionize Alpha-Gal allergy testing

NCT ID NCT07611435

First seen Jun 24, 2026 · Last updated Jul 07, 2026 · Updated 3 times

Summary

This study tests whether specially modified pork (alpha-gal knockout) causes fewer allergic reactions than regular pork in people with alpha-gal syndrome. Each of the 160 participants will eat both types of pork on different days to see which one is safer for diagnosis. The goal is to improve how doctors confirm this red meat allergy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
alpha-gal knockout pork and wild-type pork
What this could lead to
If successful, this could provide a safer and more accurate way to diagnose alpha-gal syndrome using a specially modified pork product.
What could go wrong
This is a Phase 2 trial with only 160 participants, so results may not apply to everyone. The modified pork may still cause reactions in some people.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALLERGY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Arkansas Children's Hospital Research Institute: Department of Pediatrics, Allergy & Immunology

    Little Rock, Arkansas, 72202, United States

  • North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology

    Chapel Hill, North Carolina, 27599, United States

  • University of Virginia Health System: Division of Asthma & Immunology

    Charlottesville, Virginia, 22908, United States

  • Vanderbilt University Medical Center: Division of Pediatric Allergy, Immunology, and Pulmonary Medicine

    Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.